Your browser doesn't support javascript.
loading
Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
Clément-Zhao, Alice; Tanguy, Marie-Laure; Cottu, Paul; De La Lande, Brigitte; Bontemps, Patrick; Lemanski, Claire; Baumann, Pierre; Savignoni, Alexia; Levy, Christelle; Peignaux, Karine; Reynaud-Bougnoux, Agnès; Gobillion, Aline; Kirova, Youlia.
Affiliation
  • Clément-Zhao A; Radiotherapy Department, Institut Curie, Paris, France.
  • Tanguy ML; Biostatistics Department, Institut Curie, Paris, France.
  • Cottu P; Oncology Department, Institut Curie, Paris, France.
  • De La Lande B; Radiotherapy Department, Institut Curie, Rene Huguenin Hospital, Saint Cloud, France.
  • Bontemps P; Radiotherapy Department, CHU Jean Minjoz, Besançon, France.
  • Lemanski C; Radiotherapy Department, Institut régional du Cancer de Montpellier, Montpellier, France.
  • Baumann P; Radiotherapy Department, Centre d'Oncologie de Gentilly, Nancy, France.
  • Savignoni A; Biostatistics Department, Institut Curie, Paris, France.
  • Levy C; Radiotherapy Department, Centre François Baclesse, Caen, France.
  • Peignaux K; Radiotherapy Department, Centre Georges-François Leclerc, Dijon, France.
  • Reynaud-Bougnoux A; Radiation Oncology Department, CHU Tours, Tours, France.
  • Gobillion A; Biostatistics Department, Institut Curie, Paris, France.
  • Kirova Y; Radiotherapy Department, Institut Curie, Paris, France.
PLoS One ; 14(8): e0221816, 2019.
Article in En | MEDLINE | ID: mdl-31469859
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Bevacizumab / Antineoplastic Agents, Immunological Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: PLoS One Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Bevacizumab / Antineoplastic Agents, Immunological Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: PLoS One Year: 2019 Document type: Article